Genetic testing for hereditary breast and ovarian cancer to be subsidised

2026-03-05 - 03:23

Eligible patients can receive up to 70 per cent in subsidies for genetic tests, while MediShield Life coverage will be extended to selected risk-reducing surgical procedures.